Osteoporosis in the aging population: The male perspective

Aging Male

Volumn 4, Issue 2, 2001, Pages 62-73

  Kaufman, J M ^a   Zmierczak, H ^a   Goemaere, S ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Aging; Male; Osteoporosis

Indexed keywords

TESTOSTERONE;

AGED; AGING; CLINICAL PRACTICE; DENSITOMETRY; FRACTURE; HIGH RISK POPULATION; HORMONAL THERAPY; HORMONE DEFICIENCY; HUMAN; MASCULINITY; MODEL; OSTEOPOROSIS; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; RISK FACTOR; SEX DIFFERENCE;

EID: 0034889609     PISSN: 13685538     EISSN: None     Source Type: Journal    
DOI: 10.1080/tam.4.2.62.73     Document Type: Review

References (91)

1. Osteoporosis in men
2. Osteoporosis in men
3. Osteoporosis in men
4. Background for studies on the treatment of male osteoporosis: State of the art
5. Osteoporosis and osteoporotic fractures in men: A clinical perspective
6. Bone density and risk of hip fracture in men and women: Cross sectional analysis
7. Epidemiology of fractures of the proximal femur in Geneva: Incidence, clinical and social aspects
8. Incidence of hip fractures in the elderly: A cross-national analysis
9. Age and sex pattern of hip fracture - Changes in 30 years
10. Lifetime fracture risk: An approach to hip fracture risk assessment based on bone mineral and age
11. Lifetime risk of hip fractures is underestimated
12. Hip fractures in the elderly: A world-wide projection
13. Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985-1989
14. Changes in incidence and prevalence of vertebral fractures during 30 years
15. The prevalence of vertebral deformity in European men and women: The European vertebral osteoporosis study
16. The socioeconomic burden of fractures: Today and in the 21st century
17. Rates and determinants of vertebral fracture incidence in European men and women
18. Progressive loss of bone in the femoral neck in elderly people: Longitudinal findings from the Dubbo osteoporosis epidemiology study
19. Consequences of a hip fracture: A prospective study over 1 year
20. Population-based study of survival after osteoporotic fractures
21. Mortality after all major types of osteoporotic fracture in men and women: An observational study
22. Determinants of reduced survival following hip fractures in men
23. A prospective study on socioeconomic aspects of fractures of the proximal femur
24. Direct costs of hip fractures in patients over 60 years of age in Belgium
25. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation
26. Symptomatic fracture incidence in elderly men and women: The Dubbo Osteoporosis Epidemiology Study (DOES)
27. Risk factors for increased bone loss in an elderly population. The Rotterdam study
28. Assessing bone density in men
29. Bone density and fracture risk in men
30. Bone mineral density and vertebral fractures in men
31. The predictive value of forearm bone mineral content measurements in men
32. The assessment of bone mass in men
33. Prediction of osteoporotic fractures by postural instability and bone density
34. Hip fracture prediction in elderly men and women: Validation in the Rotterdam study
35. Calcaneal bone mineral density predicts fracture occurrence. A five-year follow-up study in elderly people
36. The structural basis of bone fragility in men
37. Bone density and fracture risk in men
38. Risk factors for osteoporotic fractures in elderly men
39. Risk factors for hip fracture in a Japanese cohort
40. Risk factors for hip fracture in men from Southern Europe: The MEDOS study
41. Predictors of hip fractures in elderly men
42. Risk factors for hip fracture in men
43. Risk factors for hip fracture in white men: The NHANES I epidemiologic follow-up study
44. Assessment of sex hormones and bone mineral density in relation to occurrence of fracture in men: A prospective population-based study
45. Risk factors for spinal osteoporosis in men
46. Alcohol intake, beverage preference, and risk of hip fracture in men and women
47. An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women
48. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?
49. Management of male osteoporosis: Report of the UK Consensus Group
50. Testosterone deficiency as a risk factor for hip fractures in men: A case-control study
51. Age-related (type II) femoral neck osteoporosis in men: Biochemical evidence for both hypo-vitaminosis D- and androgen deficiency-induced bone resorption
52. Declining gonadal function in elderly men
53. Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fraction in community-dwelling men
54. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength bone density, and body composition in elderly men
55. Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling
56. 6-GnRH)
57. Androgens, bone metabolism and osteoporosis
58. Changes in quantitative bone histomorphometry in aging healthy men
59. Sex hormones and bone mineral density in elderly men
60. Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study
61. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men
62. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: The study of osteoporotic fractures
63. Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: The EPIDOS study
64. Action of androgens versus estrogens in male skeletal homeostasis
65. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
66. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgen
67. Low levels of estradiol are associated with vertebral fractures in older men, but not women: The Rancho Bernardo study
68. Indices of bone turnover in elderly men. European congress on osteoporosis, Berlin
69. Age-related changes in bone turnover in men
70. The relation between bone density, free androgen index, and estradiol in men 60 to 70 years old
71. Effect of age on bone density and bone turnover in men
72. Nyctohemeral growth hormone profiles in young and aged men: Correlation with somatomedine-C levels
73. Serum leptin levels in healthy ageing men: Are decreased serum testosterone and increased adiposity in elderly men the consequence of leptin deficiency?
74. Growth hormone and the aging male
75. Insulin-like growth factor-1 in men with idiopathic osteoporosis
76. Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men
77. Low plasma levels of insulin-like growth factor (IGF-I) in male patients with idiopathic osteoporosis
78. The role of insulin-like growth factor I in age-related changes in calcium homeostasis in men
79. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
80. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial
81. Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study
82. Increases in bone density during treatment of men with idiopathic hypogonadism
83. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism
84. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men
85. Effect of testosterone treatment on bone mineral density in men over 65 years of age
86. The effect of transdermal testosterone on bone mineral density (BMD), bone turnover markers and muscle strength in older men
87. Alendronate for the treatment of osteoporosis in men
88. Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate
89. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis
90. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers